Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation-Reference-Cited by-同舟云学术

Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation

Published:2020-03-18 Issue:1 Volume:97 Page:56-62
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Wiebe Jens¹^ORCID,Hofmann Felix J.²,Dörr Oliver²^ORCID,Bauer Timm²,Boeder Niklas²^ORCID,Liebetrau Christoph³,Blachutzik Florian²^ORCID,Möllmann Helge⁴,Elsässer Albrecht⁵,Achenbach Stephan⁶^ORCID,Hamm Christian W.²³,Nef Holger M.²

Affiliation:

1. Deutsches Herzzentrum München Technische Universität München Munich Germany

2. Medizinische Klinik I, Department of Cardiology University of Giessen Giessen Germany

3. Department of Cardiology Kerckhoff Heart and Thorax Center Bad Nauheim Germany

4. Department of Internal Medicine I St. Johannes‐Hospital Dortmund Germany

5. Department of Cardiology Klinikum Oldenburg Oldenburg Germany

6. Medizinische Klinik 2 Friedrich‐Alexander Universität Erlangen‐Nürnberg Erlangen Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28843

Reference26 articles.

1. Pathology of Drug-Eluting Stents in Humans

2. Long-Term Safety and Efficacy of Paclitaxel-Eluting Stents

3. 4-Year Clinical Outcomes and Predictors of Repeat Revascularization in Patients Treated With New-Generation Drug-Eluting Stents

4. Current Status of Bioresorbable Scaffolds in the Treatment of Coronary Artery Disease

5. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials